Literature DB >> 7251063

Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.

G Taylor, C J Howard.   

Abstract

Purified mouse immunoglobulins with specific activity against Mycoplasma pulmonis were examined for their ability to protect mice against intranasal (i.n.) infection with this organism. The survival of mycoplasmas in the respiratory tract of mice inoculated i.n. with M. pulmonis mixed with either IgG1, IgGa, IgG2b or IgA antibodies was less than that seen in control animals inoculated with mycoplasmas mixed with normal mouse serum. The ways in which the immunoglobulin fractions could have mediated resistance were examined in vitro. IgG1, IgG2a and IgG2b antibody fractions killed M. pulmonis in the presence of guinea-pig complement, and also promoted the phagocytosis of M. pulmonis by mouse lung macrophages. In contrast, IgA antibody did not appear to be either mycoplasmacidal or opsonic.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251063      PMCID: PMC1555062     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Complement-fixing IgG1 constitutes a new subclass of mouse IgG.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Nature       Date:  1979-10-11       Impact factor: 49.962

2.  Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.

Authors:  H Brunner; H B Greenberg; W D James; R L Horswood; R B Couch; R M Chanock
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

5.  Activation of mouse complement by different classes of mouse antibody.

Authors:  G G Klaus; M B Pepys; K Kitajima; B A Askonas
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

6.  Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis.

Authors:  G H Cassell; J R Lindsey; H J Baker
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

7.  IgG1 and IgG2b share the Fc receptor on mouse macrophages.

Authors:  B Diamond; M D Scharff
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

8.  Interaction of Mycoplasma pulmonis with mouse peritoneal macrophages and polymorphonuclear leucocytes.

Authors:  G Taylor; C J Howard
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

9.  Immunity to Mycoplasma bovis infections of the respiratory tract of calves.

Authors:  C J Howard; R N Gourlay; G Taylor
Journal:  Res Vet Sci       Date:  1980-03       Impact factor: 2.534

10.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state.

Authors:  A B van oud Alblas; R van Furth
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

View more
  10 in total

1.  Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.

Authors:  J W Simecka; R J Jackson; H Kiyono; J R McGhee
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Genetic control of resistance to Mycoplasma pulmonis infection in mice.

Authors:  W C Lai; G Linton; M Bennett; S P Pakes
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

3.  Resistance to mycoplasmal lung disease in mice is a complex genetic trait.

Authors:  S C Cartner; J W Simecka; D E Briles; G H Cassell; J R Lindsey
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; M H Weiner; B Grubbs
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

5.  Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice.

Authors:  J K Davis; R F Parker; H White; D Dziedzic; G Taylor; M K Davidson; N R Cox; G H Cassell
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

6.  Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Authors:  S C Cartner; J W Simecka; J R Lindsey; G H Cassell; J K Davis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Vaccination of Lewis rats with temperature-sensitive mutants of Mycoplasma pulmonis: adoptive transfer of immunity by spleen cells but not by sera.

Authors:  W C Lai; M Bennett; Y S Lu; S P Pakes
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Roles of innate and adaptive immunity in respiratory mycoplasmosis.

Authors:  S C Cartner; J R Lindsey; J Gibbs-Erwin; G H Cassell; J W Simecka
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  Experimental contagious caprine pleuropneumonia: a long term study on the course of infection and pathology in a flock of goats infected with Mycoplasma capricolum subsp. capripneumoniae.

Authors:  H O Wesonga; G Bölske; F Thiaucourt; C Wanjohi; R Lindberg
Journal:  Acta Vet Scand       Date:  2004       Impact factor: 1.695

10.  Interaction of mycoplasmas and phagocytes.

Authors:  C J Howard; G Taylor
Journal:  Yale J Biol Med       Date:  1983 Sep-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.